Search Results - "Tsimberidou AM"

Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience.

Authors: Vaklavas C Tsimberidou AM Wen S et al.

Source: Cancer (0008543X). 1/1/2011, Vol. 117 Issue 1, p77-85. 9p.

Phase 1 first-in-human clinical study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.

Authors: Tsimberidou AM Rudek MA Hong D et al.

Source: Cancer Chemotherapy & Pharmacology. Jan2010, Vol. 65 Issue 2, p235-241. 7p.

Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience.

Authors: Wheler J Tsimberidou AM Hong D et al.

Source: Cancer (0008543X). 3/1/2009, Vol. 115 Issue 5, p1091-1099. 9p.

A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.

Authors: El-Khoueiry AB Lieu CH Abou-Alfa GK et al.

Source: Liver cancer [Liver Cancer] 2026 Mar 30. Date of Electronic Publication: 2026 Mar 30.

Publication Type: Journal Article

Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer

Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.

Authors: Torrado C Andersen CR Kang L et al.

Source: The oncologist [Oncologist] 2026 Mar 09; Vol. 31 (4).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.

Authors: Schmidt ST Baysal MA Fu S et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Feb 24; Vol. 11 (1). Date of Electronic Publication: 2026 Feb 24.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Phase 2 dose-expansion trial of OBI-3424, a DNA-alkylating prodrug, in patients with advanced solid tumors expressing AKR1C3.

Authors: Tsimberidou AM Verschraegen C Sigal D et al.

Source: The oncologist [Oncologist] 2026 Jul 08; Vol. 31 (8).

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Authors: Veljovich DS Rothe M Garrett-Mayer E et al.

Source: JCO precision oncology [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2600456. Date of Electronic Publication: 2026 Jul 15.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.

Authors: Tsimberidou AM Sigal D Varghese A et al.

Source: The oncologist [Oncologist] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.

Authors: Derbala MH Stephen B Hwang W et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jun 24; Vol. 14 (6). Date of Electronic Publication: 2026 Jun 24.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

Authors: Lockwood CM Messersmith HJ Kim AS et al.

Source: JCO oncology practice [JCO Oncol Pract] 2026 Jun 18, pp. OP2600311. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumors.

Authors: Fountzilas E Kurzrock R Nishizaki D et al.

Source: ImmunoTargets and therapy [Immunotargets Ther] 2026 May 04; Vol. 15, pp. 578703. Date of Electronic Publication: 2026 May 04 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101606565 Publication Model: eCollection Cited Medium: Print ISSN: 2253-1556 (Print) Linking ISSN: 22531556 NLM ISO Abbreviation: Immunotargets Ther Subsets: PubMed not MEDLINE

Prolonged response to dual immune checkpoint blockade in patients with advanced solid tumors: a case series.

Authors: Xavier CB Gouda MA Tsimberidou AM

Source: NPJ precision oncology [NPJ Precis Oncol] 2025 Oct 09; Vol. 9 (1), pp. 322. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors.

Authors: Tsimberidou AM Dayyani F Sommerhalder D et al.

Source: The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study.

Authors: Venturini J Baysal MA Chakraborty A et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Apr 10; Vol. 10 (1). Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial.

Authors: Nardo M Gouda MA Reilley MJ et al.

Source: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2025 Feb 07; Vol. 8 (2), pp. 89-98. Date of Electronic Publication: 2025 Feb 07 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.

Authors: Ahmed J Janku F Karp DD et al.

Source: Cancer [Cancer] 2025 Feb 01; Vol. 131 (3), pp. e35728.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors.

Authors: Tsimberidou AM Grothey A Sigal D et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Dec; Vol. 94 (6), pp. 787-798. Date of Electronic Publication: 2024 Sep 23.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.

Authors: Lim JU Lin HY Kang L et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Jan 13; Vol. 10 (1), pp. 59. Date of Electronic Publication: 2026 Jan 13.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Metastatic extraneural glioblastoma diagnosed with molecular testing.

Authors: Majd NK Vo HH Moran CA et al.

Source: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 811-816.

Publication Type: Journal Article; Case Reports; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE